GYRE THERAPEUTICS, INC. has raised $5.0M in total funding. The most recent round was Series B.
GYRE THERAPEUTICS, INC. is headquartered in San Diego, CA.
Already a publicly traded company on Nasdaq (ticker: GYRE), not a typical early-stage startup; it recently completed an acquisition of Cullgen to create a combined US/China drug-development operation.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.